Device
Sublingual Microcirculation
Sublingual Microcirculation is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completed
Blood Volume Assessment in COVID-19 and Bacterial Sepsis
NCT04517695
unknownnot_applicable
Comparison of Microcirculation Indexes and Hemodynamic Indexes to Guide Resuscitation in Patients With Septic Shock
NCT05118646
completed
Predictive Value of Sublingual Microcirculation and Peripheral Tissue Oxygen Monitoring
NCT03859726
Clinical Trials (3)
Showing 3 of 3 trials
NCT04517695
Blood Volume Assessment in COVID-19 and Bacterial Sepsis
NCT05118646Not Applicable
Comparison of Microcirculation Indexes and Hemodynamic Indexes to Guide Resuscitation in Patients With Septic Shock
NCT03859726
Predictive Value of Sublingual Microcirculation and Peripheral Tissue Oxygen Monitoring
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3